Clinical Trials Browser

Has results × Itraconazole × Clear all

NCT02157883 2025-11-19

Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)

Phase 1 Completed

39 enrolled 18 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02875223 2025-04-20

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Phase 1 Terminated

75 enrolled 35 charts

Lymphoid

Lymphoma, Non-Hodgkin, Neoplasms

NCT04537715 2025-02-19

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Phase 1 Completed

42 enrolled 39 charts

LymphoidOther hematologic neoplasmOther solid neoplasmSarcomaThoracic

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

NCT03994211 2024-10-26

Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer

Phase 1 Completed

25 enrolled 33 charts

Other solid neoplasm

Solid Tumor

NCT03383692 2023-12-11

Study of DS-8201a for Participants With Advanced Solid Malignant Tumors

Phase 1 Completed

40 enrolled 20 charts

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT01772563 2023-09-01

Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours

Phase 1 Completed

28 enrolled 10 charts

Tumor-Agnostic

Neoplasms

NCT03077607 2021-06-30

A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors

Phase 1 Completed

36 enrolled 28 charts

Other solid neoplasm

Advanced Solid Tumors

NCT02357836 2021-05-03

Neoadjuvant Itraconazole in Non-small Cell Lung Cancer

Phase EARLY_PHASE1 Completed

13 enrolled 12 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01787331 2020-02-05

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Phase 2 Completed

21 enrolled 16 charts

Genitourinary

Prostatic Neoplasms

NCT02259010 2019-09-20

A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Phase 1 Completed

24 enrolled 26 charts

Lymphoid

Lymphoma

NCT00769600 2019-02-01

Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC

Phase 2 Terminated

23 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02122770 2019-01-07

Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors

Phase 1 Completed

51 enrolled 30 charts

Other solid neoplasm

Advanced Solid Tumors

NCT00887458 2017-10-16

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Phase 2 Completed

46 enrolled 8 charts

Genitourinary

Prostatic Neoplasms

NCT01450683 2017-04-11

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Phase 2 Terminated

4 enrolled 4 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT01021683 2013-08-12

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Completed

203 enrolled 14 charts

Other hematologic neoplasm

Fever, Neutropenia, Hematologic Neoplasms